MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 159 filers reported holding MOMENTA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $7,548,000 | +72.5% | 143,825 | +9.4% | 0.01% | +66.7% |
Q2 2020 | $4,376,000 | +161.6% | 131,521 | +113.9% | 0.00% | +200.0% |
Q1 2020 | $1,673,000 | -50.9% | 61,492 | -64.4% | 0.00% | -50.0% |
Q4 2019 | $3,404,000 | +366.3% | 172,598 | +205.7% | 0.00% | +100.0% |
Q3 2019 | $730,000 | -11.0% | 56,462 | -14.5% | 0.00% | – |
Q2 2019 | $820,000 | -24.0% | 66,041 | -11.2% | 0.00% | -100.0% |
Q1 2019 | $1,079,000 | +2.4% | 74,386 | -22.3% | 0.00% | 0.0% |
Q4 2018 | $1,054,000 | -91.7% | 95,675 | -80.3% | 0.00% | -75.0% |
Q3 2018 | $12,771,000 | +42.6% | 485,705 | +10.9% | 0.00% | +33.3% |
Q2 2018 | $8,955,000 | +83.7% | 437,960 | +63.0% | 0.00% | +50.0% |
Q1 2018 | $4,875,000 | +100.1% | 268,694 | +53.7% | 0.00% | 0.0% |
Q4 2017 | $2,436,000 | +27.5% | 174,820 | +68.9% | 0.00% | +100.0% |
Q3 2017 | $1,911,000 | +13.1% | 103,516 | +3.4% | 0.00% | 0.0% |
Q2 2017 | $1,690,000 | +607.1% | 100,120 | +455.0% | 0.00% | – |
Q1 2017 | $239,000 | -66.0% | 18,039 | -61.5% | 0.00% | -100.0% |
Q4 2016 | $703,000 | -45.5% | 46,795 | -57.6% | 0.00% | 0.0% |
Q3 2016 | $1,290,000 | -51.8% | 110,449 | -55.5% | 0.00% | -50.0% |
Q2 2016 | $2,677,000 | +1.4% | 248,009 | -13.3% | 0.00% | 0.0% |
Q1 2016 | $2,640,000 | -33.0% | 285,974 | +7.6% | 0.00% | -33.3% |
Q4 2015 | $3,943,000 | -27.0% | 265,836 | -19.2% | 0.00% | -25.0% |
Q3 2015 | $5,400,000 | -12.4% | 329,146 | +21.8% | 0.00% | 0.0% |
Q2 2015 | $6,162,000 | +150.1% | 270,207 | +66.5% | 0.00% | +100.0% |
Q1 2015 | $2,464,000 | +101.5% | 162,331 | +59.6% | 0.00% | +100.0% |
Q4 2014 | $1,223,000 | -41.5% | 101,681 | -44.8% | 0.00% | 0.0% |
Q3 2014 | $2,090,000 | -48.7% | 184,340 | -45.4% | 0.00% | -66.7% |
Q2 2014 | $4,076,000 | +1.2% | 337,466 | -2.6% | 0.00% | 0.0% |
Q1 2014 | $4,027,000 | +220.6% | 346,477 | +387.2% | 0.00% | +200.0% |
Q4 2013 | $1,256,000 | -49.4% | 71,112 | -58.8% | 0.00% | -50.0% |
Q3 2013 | $2,484,000 | – | 172,671 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 159,197 | $5,296,000 | 4.06% |
Ghost Tree Capital, LLC | 385,000 | $12,809,000 | 3.38% |
Copernicus Capital Management, LLC | 88,000 | $2,928,000 | 3.21% |
Palo Alto Investors LP | 1,479,524 | $49,224,000 | 2.96% |
Redmile Group, LLC | 4,705,308 | $156,546,000 | 2.89% |
Avidity Partners Management LP | 1,150,000 | $38,261,000 | 2.45% |
RA Capital Management | 2,531,445 | $84,221,000 | 1.64% |
MAVERICK CAPITAL LTD | 2,314,756 | $77,012,000 | 1.62% |
Integral Health Asset Management, LLC | 150,000 | $4,991,000 | 1.50% |
PFM Health Sciences, LP | 579,994 | $19,296,000 | 1.00% |